Excess deaths from all causes and by Covid-19 in Brazil in 2020

Dados Bibliográficos

ID16780225
AutoresAlcione Miranda Dos Santos (0000-0001-9711-0182, Universidade Federal do Maranhão), Bruno Feres De Souza (0000-0003-1997-4983, Universidade Federal do Maranhão), Carolina Abreu De Carvalho (0000-0001-7900-4642, Universidade Federal do Maranhão), Marcos Adriano Garcia Campos (0000-0001-8924-1203, Universidade Federal do Maranhão), Bruno Luciano Carneiro Alves De Oliveira (0000-0001-8053-7972, Universidade Federal do Maranhão), Eliezer M Diniz (0000-0002-6201-1771, Universidade Federal do Maranhão), Maria Dos Remédios Freitas Carvalho Branco (0000-0002-3537-0840, Universidade Federal do Maranhão), Rejane Christine De Sousa Queiroz (0000-0003-4019-2011, Universidade Federal do Maranhão), Vitória Abreu De Carvalho (0000-0002-7831-5761, Universidade Federal do Maranhão), Waleska Regina Machado Araújo (0000-0001-5758-7947, Universidade de São Paulo), Antonio Augusto Moura Da Silva (0000-0003-4968-5138, Universidade Federal do Maranhão)
Ano2021
Volume55
Páginas71
Data de publicação2021-10-29
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoRevista de Saúde Pública (JOURNAL)
Identificadores do periódicoISSN: 0034-8910 • E-ISSN: 0034-8910
EditoraUniversidade de São Paulo. Agência de Bibliotecas e Coleções Digitais (PUBLISHER)
DOI10.11606/s1518-8787.2021055004137
PMID34730751
OpenAlexW3210690442
IdiomaEN
Citações recebidas11
Referências citadas10

OBJECTIVE To estimate the 2020 all-cause and COVID-19 excess mortality according to sex, age, race/color, and state, and to compare mortality rates by selected causes with that of the five previous years in Brazil. METHODS Data from the Mortality Information System were used. Expected deaths for 2020 were estimated from 2015 to 2019 data using a negative binomial log-linear model. RESULTS Excess deaths in Brazil in 2020 amounted to 13.7%, and the ratio of excess deaths to COVID-19 deaths was 0.90. Reductions in deaths from cardiovascular diseases (CVD), respiratory diseases, and external causes, and an increase in ill-defined causes were all noted. Excess deaths were also found to be heterogeneous, being higher in the Northern, Center-Western, and Northeastern states. In some states, the number of COVID-19 deaths was lower than that of excess deaths, whereas the opposite occurred in others. Moreover, excess deaths were higher in men aged 20 to 59, and in black, yellow, or indigenous individuals. Meanwhile, excess mortality was lower in women, in individuals aged 80 years or older, and in whites. Additionally, deaths among those aged 0 to 19 were 7.2% lower than expected, with reduction in mortality from respiratory diseases and external causes. There was also a drop in mortality due to external causes in men and in those aged 20 to 39 years. Moreover, reductions in deaths from CVD and neoplasms were noted in some states and groups. CONCLUSION There is evidence of underreporting of COVID-19 deaths and of the possible impact of restrictive measures in the reduction of deaths from external causes and respiratory diseases. The impacts of COVID-19 on mortality were heterogeneous among the states and groups, revealing that regional, demographic, socioeconomic, and racial differences expose individuals in distinct ways to the risk of death from both COVID-19 and other causes

Cause of death · Coronavirus disease 2019 (COVID-19) · Disease · Excess mortality · Mortality rate · COVID-19 and healthcare impacts · COVID-19 Clinical Research Studies · COVID-19 epidemiological studies · Demography · Epidemiology · Internal Medicine · Medicine